Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 1217, 2006; 10.1373/clinchem.2006.071316
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Lamballerie, X.
Right arrow Articles by Colson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Lamballerie, X.
Right arrow Articles by Colson, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2006;52:1217.)
© 2006 American Association for Clinical Chemistry, Inc.

Editorial

The Battle against Infectious Diseases in Developing Countries: The Inseparable Twins of Diagnosis and Therapy

Xavier de Lamballeriea and Philippe Colson

University of Marseille, Marseille, France

aAddress correspondence to this author at: Medical University, 27 bd Jean Moulin, 13005 Marseille, France. E-mail xndl-virophdm@gulliver.fr.

The first 20% of the full text of this article appears below.

The lack of treatment of infectious diseases in developing countries is a tragic problem and one of the most serious challenges that the world must face at the beginning of this century. Hundreds of millions of people suffer from transmissible diseases for which treatments exist but for which the patients are not receiving treatment. The case of HIV infection is symbolic: the vast majority of patients are living in countries where access to treatment is difficult, incomplete, or impossible.

The problem of access to treatment has been discussed frequently. By contrast, its crucial connections with the problem of diagnosis are rarely enunciated. However, identification of the etiology of an infectious disease and monitoring of the infection during therapy are required for effective and efficient treatment.

In this issue of Clinical . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.